Calcium Channel Blockers of Dihydropyridine Class Reduce The Antiplatelet Effect of Clopidogrel? What Is Clinical Impact

被引：2
|
作者：
Park, Sang Ho [1 ]
Rha, Seung-Woon [2 ]
Shin, Won-Yong [1 ]
Lee, Seung-Jin [1 ]
Jin, Dong-Kyu [1 ]
Lee, Se-Whan [1 ]
Park, Ji Young [2 ]
Choi, Byoung Geol [2 ]
Poddar, Kanhaiya L. [2 ]
Kumari, Meera [2 ]
Kim, Yun Kyung [2 ]
Na, Jin Oh [2 ]
Choi, Cheol Ung [2 ]
Lim, Hong Euy [2 ]
Kim, Jin Won [2 ]
Kim, Eung Ju [2 ]
Park, Chang Gyu [2 ]
Seo, Hong Seog [2 ]
Oh, Dong Joo [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Cheonan, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2011年 / 107卷 / 8A期
关键词：
D O I：
10.1016/j.amjcard.2011.02.109
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：47A / 47A
页数：1
相关论文
共 50 条
  • [21] EFFECT OF INORGANIC CALCIUM-CHANNEL BLOCKERS ON DIHYDROPYRIDINE BINDING TO CARDIAC SARCOLEMMA
    SCHILLING, WP
    ZAHER, MC
    RAMPE, D
    MOLECULAR PHARMACOLOGY, 1990, 37 (01) : 80 - 89
  • [22] Dihydropyridine calcium channel blockers and peripheral side effects
    A Sirker
    CG Missouris
    GA MacGregor
    Journal of Human Hypertension, 2001, 15 : 745 - 746
  • [23] PROISCHEMIC COMPLICATIONS OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    WATERS, D
    CIRCULATION, 1991, 84 (06) : 2598 - 2600
  • [24] Dihydropyridine calcium channel blockers and peripheral side effects
    Sirker, A
    Missouris, CG
    MacGregor, GA
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (10) : 745 - 746
  • [25] Calcium channel blockers do not modify the clinical efficacy of clopidogrel: a nationwide study
    Olesen, J. B.
    Gislason, G. H.
    Chariot, M.
    Andersson, C.
    Weeke, P.
    Fosbol, E. L.
    Hansen, M. L.
    Ahlehoff, O.
    Torp-Pedersen, C.
    Hansen, P. R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 906 - 906
  • [26] Life-threatening interaction of mibefradil and β-blockers with dihydropyridine calcium channel blockers
    Mullins, ME
    Horowitz, BZ
    Linden, DHJ
    Smith, GW
    Norton, RL
    Stump, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02): : 157 - 158
  • [27] Chalcones as potent antiplatelet agents and calcium channel blockers
    Lin, CN
    Hsieh, HK
    Ko, HH
    Hsu, MF
    Lin, HC
    Chang, YL
    Chung, MI
    Kang, JJ
    Wang, JP
    Teng, CM
    DRUG DEVELOPMENT RESEARCH, 2001, 53 (01) : 9 - 14
  • [28] Anti-Atherosclerotic Potential of Dihydropyridine Calcium Channel Blockers
    Ishii, Norio
    Matsumura, Takeshi
    Shimoda, Seiya
    Araki, Eiichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (08) : 693 - 704
  • [29] SPECIFIC NEUROTROPIC EFFECTS OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    KOCH, HJ
    DINSE, HR
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1994, 16 (10): : 687 - 689
  • [30] Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?
    Khitan, Zeid J.
    Tzamaloukas, Antonios H.
    Brodsky, Sergey
    Shapiro, Joseph I.
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01): : 203 - 204
12345